(Total Views: 94)
Posted On: 03/16/2024 8:05:52 AM
Post# of 144650
$GSK News Article - Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer https://marketwirenews.com/news-releases/posi...08867.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
